🔥🐔 BizChicken 🐔🔥
Companies Similar to Castle Biosciences, Inc.
Sign Up Today!
Sign up for BizChicken and discover more about the corporations around you.
Co-Diagnostics, Inc.
PCR diagnostic tests
Co-Diagnostics, Inc. develops, manufactures, and sells reagents for diagnostic tests that detect nucleic acid molecules, offering PCR tests for various diseases including COVID-19 and providing molecular diagnostic tools for healthcare and agricultural applications.
Symbol: CODX
Recent Price: $0.70
Industry: Medical - Devices
CEO: Mr. Dwight H. Egan
Sector: Healthcare
Employees: 155
Address: 2401 South Foothill Drive, Salt Lake City, UT 84109
Phone: 801 438 1036
Last updated: 2024-12-31
Castle Biosciences, Inc.
Decision Dx-Melanoma
Castle Biosciences, Inc. is a commercial-stage diagnostics company providing diagnostic and prognostic testing services for dermatological cancers, including products like Decision Dx-Melanoma for invasive cutaneous melanoma and other proprietary GEP tests.
Contact | About | Contact | Leadership | About | ESG | About | Careers | About | About | About | About
Symbol: CSTL
Recent Price: $26.66
Industry: Medical - Diagnostics & Research
CEO: Mr. Derek J. Maetzold
Sector: Healthcare
Employees: 710
Address: 505 South Friendswood Drive, Friendswood, TX 77546
Phone: 866 788 9007
Leadership
- Derek Maetzold, Founder, President, CEO and Director
- Frank Stokes, Chief Financial Officer
- Kristen Oelschlager, CHIEF OPERATING OFFICER
- Toby Juvenal, CHIEF COMMERCIAL OFFICER
- Sherri Borman, Ph.D., Executive Laboratory Director
- John Abbott, VICE PRESIDENT, FINANCE
- Rebecca Critchley-Thorne, Ph.D., vice president, research & development
- Jay Braxton, Pharm.D., Vice President, Marketing and brand manager, uveal melanoma (um)
- Hillary Caruso, Ph.D., Vice President, Strategic Operations
- John Cheneval, Executive Director, Business Development
- Kevin Doman, Vice President, Sales
- Vicki Fish, Vice President, Skin Cancer Marketing
- Matthew Goldberg, M.D., Senior vice president, medical
- Keli Greenberg, Vice President, Human Resources
- Alice Izzo, Vice President, regulatory and government affairs
- Clare Johnson, R.N., Vice President, Clinical Research
- Michael Maltby, Executive Director, Managed Care
- Noreen Manning, Vice President, Reimbursement
- Chris Otte, Vice President, Information Technology
- Trisha Poteet, Vice President, Clinical Services
- Camilla Zuckero, Vice President, Investor Relations & Corporate Affairs
- Daniel Bradbury, Board Chairman
- Kimberlee Caple, Director
- G. Bradley Cole, Director
- Rodney Cotton, Director
- Ellen Goldberg, Director
- Miles Harrison, Director
- Tiffany Olson, Director
Last updated: 2024-12-31
iCAD, Inc.
Power Look platform
i CAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States, with segments in Cancer Detection and Cancer Therapy.
News | About | About | History | About | About | News | News | About | News | News | News | News | Contact | Careers | Careers | Careers | About | About | About | About | About | About
Symbol: ICAD
Recent Price: $1.92
Industry: Medical - Devices
CEO: Ms. Dana R. Brown
Sector: Healthcare
Employees: 67
Address: 98 Spit Brook Road, Nashua, NH 03062
Phone: 603 882 5200
Last updated: 2024-12-31
T2 Biosystems, Inc.
T2Dx Instrument
T2 Biosystems, Inc. develops in vitro diagnostic products for detecting pathogens, biomarkers, and abnormalities in various patient sample types.
About | Vision/Values | News | Leadership | Events | About | About | About | About | Vision/Values | Leadership | About | About | Contact | Contact | About | About | About | About | Careers | Careers | Careers | Careers | Careers | Careers | About | About | About | Jobs | About
Symbol: TTOO
Recent Price: $0.42
Industry: Medical - Diagnostics & Research
CEO: Mr. John J. Sperzel III, B.Sc.
Sector: Healthcare
Employees: 113
Address: 101 Hartwell Avenue, Lexington, MA 02421
Phone: 781 761 4646
Leadership
- John Sperzel, Chairman and Chief Executive Officer
- Michael Gibbs, Esq., SVP and General Counsel
- Brett Giffin, Chief Commercial Officer
- Kelley Morgan, Chief People Officer
- Roger Smith, SVP, Science, Research and Development
- John Sprague, Chief Financial Officer
- Laura Adams, Special Advisor at the National Academy of Medicine (NAM)
- John W. Cumming, CEO and Managing Director, Cumming & Associates LLC
- David Elsbree, Former Senior Partner, Deloitte & Touche
- Dr. Ninfa M. Saunders, FACHE, President and CEO, Navicent Health
- Robin Toft, Founder and CEO, Toft Group
Last updated: 2024-12-31
Arcellx, Inc.
CART-dd BCMA
Arcellx, Inc. is a clinical-stage biotechnology company dedicated to developing immunotherapies for cancer and other incurable diseases, with a focus on its lead product candidate, CART-dd BCMA, for treating relapsed or refractory multiple myeloma.
About | About | News | Contact | Contact | Culture | Culture | Culture | Culture | About | About | About | About | About | News
Symbol: ACLX
Recent Price: $78.35
Industry: Biotechnology
CEO: Mr. Rami Elghandour
Sector: Healthcare
Employees: 130
Address: 25 West Watkins Mill Road, Gaithersburg, MD 20878
Phone: 240 327 0603
Last updated: 2024-12-31
Black Diamond Therapeutics, Inc.
BDTX-189, BDTX-1535, BDTX-4933
Black Diamond Therapeutics, Inc. is a biotechnology company that discovers, develops, and commercializes medicines for patients with genetically defined tumors. The company focuses on creating irreversible small molecule inhibitors to target specific oncogenic proteins.
Symbol: BDTX
Recent Price: $2.15
Industry: Biotechnology
CEO: Dr. Mark A. Velleca M.D., Ph.D.
Sector: Healthcare
Employees: 54
Address: One Main Street, Cambridge, MA 02142
Phone: 617 252 0848
Leadership
- Ali Behbahani, M.D., Co-Head of Healthcare, NEA
- Shannon Campbell, Executive Vice President and Chief Commercial Officer, Merus
- Kapil Dhingra, M.D., Former Head, Roche Oncology Development
- Samarth (Sam) Kulkarni, Ph.D., CEO, CRISPR Therapeutics AG
- Garry E. Menzel, Ph.D., Operating Partner, GHO Capital Partners LLP
- Prakash Raman, Ph.D., CEO of InduPro, Inc.
- Mark A. Velleca, M.D., Ph.D., CEO and Board Chair
Last updated: 2024-12-31
Cabaletta Bio, Inc.
DSG3-CAART
Cabaletta Bio, Inc. is a clinical-stage biotechnology company focused on developing engineered T cell therapies for B cell-mediated autoimmune diseases. Its leading product, DSG3-CAART, is in Phase I trials for treating mucosal pemphigus vulgaris.
Symbol: CABA
Recent Price: $2.24
Industry: Biotechnology
CEO: Dr. Steven A. Nichtberger M.D.
Sector: Healthcare
Employees: 136
Address: 2929 Arch Street, Philadelphia, PA 19104
Phone: 267 759 3100
Leadership
- Steven Nichtberger, M.D., President, Chief Executive Officer, and Co-Founder
- Samik Basu, M.D., Chief Scientific Officer
- Gwendolyn Binder, Ph.D., President, Science & Technology
- David J. Chang, M.D., M.P.H, FACR, Chief Medical Officer
- Arun Das, M.D., Chief Business Officer
- Michael Gerard, General Counsel
- Heather Harte-Hall, Chief Compliance Officer
- Anup Marda, Chief Financial Officer
- Martha O’Connor, Chief Human Resources Officer
- Sarah Yuan, Ph.D., Chief Technology Officer
- Catherine Bollard, M.D., Independent Director, George Washington University
- Scott Brun, M.D., Independent Director, formerly at AbbVie
- Richard Henriques, M.B.A., Independent Director, former CFO of Gates Foundation, former Controller at Merck
- Mark Simon, M.B.A., Independent Director, Torreya Partners
- Shawn Tomasello, M.B.A., Independent Director, former CCO of Kite Pharma, Inc.
Last updated: 2024-12-31
Celularity Inc.
CYCART-19, CYNK-001, CYNK-101, APPL-001, PDA-002
Celularity Inc., a clinical-stage biotechnology company, develops off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer, immune, and infectious diseases. It operates through three segments: Cell Therapy, Degenerative Disease, and Bio Banking.
About | Leadership | Directors | About | About | About | About | Directors | Careers | About | About | About | About | About | About
Symbol: CELU
Recent Price: $2.05
Industry: Biotechnology
CEO: Dr. Robert Joseph Hariri M.D., Ph.D.
Sector: Healthcare
Employees: 120
Address: 170 Park Avenue, Florham Park, NJ 07932
Phone: 908 768 2170
Leadership
- Robert J. Hariri, M.D., Ph.D., Chairperson, Founder, and CEO
- David Beers, CFA, Chief Financial Officer
- Stephen Brigido, DPM, President, Degenerative Diseases
- John Haines, Global Manager and Chief Administrative Officer
- K. Harold Fletcher, Esq., General Counsel & Chief Compliance Officer
- John Colerangle, DVM, Ph.D., Regulatory Affairs
- Anna Gosiewska, Ph.D., R&D, Degenerative Diseases
- Sharmila Koppisetti, M.D., Clinical Development Immunology & Drug Safety
- Carmine Palummo, Corporate Operations
- Tim Wilk, Technical Operations
- Robert J. Hariri, M.D., Ph.D, Chairperson, Founder & CEO
- Peter Diamandis, M.D., Director
- Dean Kehler, Director
- Geoffrey Shiu Fei Ling, M.D., Ph.D., Director
- Diane Parks, Director
Last updated: 2024-12-31
Cellectar Biosciences, Inc.
CLR 131
Cellectar Biosciences, Inc. is a clinical biopharmaceutical company concentrating on the development and commercialization of drugs for cancer treatment.
Symbol: CLRB
Recent Price: $0.29
Industry: Biotechnology
CEO: Mr. James V. Caruso
Sector: Healthcare
Employees: 20
Address: 100 Campus Drive, Florham Park, NJ 07932
Phone: 608 441 8120
Leadership
- James Caruso, President, CEO and Director
- Chad Kolean, Chief Financial Officer
- Shane Lea, Chief Commercial Officer
- Jarrod Longcor, Chief Operating Officer
- Andrei Shustov, Senior Vice President, Medical
- Douglas J. Swirsky, Chairman of the Board
- Asher Alban Chanan-Khan, MD., Director
- Frederick W. Driscoll, Director
- Stefan D. Loren, Ph.D., Director
- John Neis, Director
- Cellectar Biosciences, Inc., Company Information
Last updated: 2024-12-31
Delcath Systems, Inc.
HEPZATO KIT
Delcath Systems, Inc. is an interventional oncology company focused on the treatment of primary and metastatic liver cancers in the United States and Europe, with its lead product candidate being the HEPZATO KIT.
Symbol: DCTH
Recent Price: $11.89
Industry: Medical - Specialties
CEO: Mr. Gerard J. Michel MBA, MS
Sector: Healthcare
Employees: 76
Address: 1633 Broadway, New York, NY 10019
Phone: 212 489 2100
Last updated: 2024-12-31
Dermata Therapeutics, Inc.
DMT310
Dermata Therapeutics, Inc. is a clinical-stage biotechnology company specializing in the development and commercialization of pharmaceutical candidates for treating medical and aesthetic skin conditions. The company focuses on products such as DMT310 for acne, rosacea, and psoriasis, and DMT410 for hyperhidrosis and aesthetic conditions.
Symbol: DRMA
Recent Price: $1.34
Industry: Biotechnology
CEO: Mr. Gerald T. Proehl
Sector: Healthcare
Employees: 8
Address: 3525 Del Mar Heights Road, San Diego, CA 92130
Phone: 858 800 2543
Last updated: 2024-12-31
Fortress Biotech, Inc.
Pharmaceutical and Biotechnology Products
Fortress Biotech, Inc., is a biopharmaceutical company focused on developing and commercializing a range of dermatology products and late-stage product candidates for various medical conditions.
About | About | About | Leadership | Directors | About | About | Contact | Careers | Careers | Careers | About | About | About
Symbol: FBIO
Recent Price: $2.18
Industry: Biotechnology
CEO: Dr. Lindsay Allan Rosenwald
Sector: Healthcare
Employees: 186
Address: 1111 Kane Concourse, Bay Harbor Islands, FL 33154
Phone: 781 652 4500
Leadership
- Lindsay A. Rosenwald, M.D., Chairman, President and Chief Executive Officer
- Michael S. Weiss, Executive Vice Chairman, Strategic Development
- David Jin, Chief Financial Officer and Head of Corporate Development
- George Avgerinos, Ph.D., Senior Vice President, Biologics Operations
- Samuel Berry, General Counsel and Corporate Secretary
- Jimmie Harvey, Jr., M.D., Director
- Malcolm Hoenlein, Director
- Dov Klein, Director
- J. Jay Lobell, Director
- Kevin L. Lorenz, J.D., Director
- Lucy Lu, M.D., Director
Last updated: 2024-12-31
Spectral AI, Inc.
Deep View
Spectral AI, Inc. focuses on AI-driven medical diagnostics for wound care, providing faster and more accurate treatment decisions with applications for burns and diabetic foot ulcers.
Symbol: MDAI
Recent Price: $3.05
Industry: Medical - Devices
CEO: Mr. Wensheng Fan
Sector: Healthcare
Employees: 78
Address: 2515 McKinney Avenue, Dallas, TX 75201
Phone: 972-499-4934
Leadership
- Dr. J Michael DiMaio, Chairman of the Board
- Vince Capone, Chief Financial Officer and General Counsel
- Jeremiah Sparks, Chief Commercialization Officer
- Stan Micek, Interim Chief Operating Officer
- Louis Percoco, General Manager – Manufacturing
- Mary Regan, Ph.D., Vice President, Clinical Affairs
- Christine Marks, Vice President, Marketing & Commercialization
- Prof. Paul Chadwick, Executive Vice President
Last updated: 2024-12-31
NeoGenomics, Inc.
Cancer-focused testing services
Neo Genomics, Inc. operates a network of cancer-focused testing laboratories offering various services such as cytogenetics, fluorescence in-situ hybridization, flow cytometry, immunohistochemistry, digital imaging, and molecular testing.
About | About | Leadership | Benefits | About | About | About | About | About | About | Contact | About | About | About
Symbol: NEO
Recent Price: $16.92
Industry: Medical - Diagnostics & Research
CEO: Mr. Christopher Michael Smith BSc
Sector: Healthcare
Employees: 2100
Address: 9490 NeoGenomics Way, Fort Myers, FL 33912
Phone: 239 768 0600
Leadership
- Chris Smith, Chief Executive Officer
- Jeff Sherman, Chief Financial Officer
- Warren Stone, Chief Commercial Officer
- Melody Harris, Chief Operations Officer & President, Informatics
- Ali Olivo, Executive Vice President, General Counsel & Business Development
- Hutan Hashemi, JD, Chief Compliance Officer
- Nathan Montgomery, MD, PhD, Vice President, Medical Services
- Gary Passman, Chief Culture Officer
- Kareem Saad, Head of Strategy and Transformation
- Lynn A. Tetrault, Chair of the Board
- Bruce K. Crowther, Board Member
- Elizabeth Floegel, Board Member
- Neil Gunn, Board Member
- Alison L. Hannah, MD, Board Member
- Stephen Kanovsky, Board Member
- Michael A. Kelly, Board Member
- David Perez, Board Member
- Tony Zook, Board Member
- Derek Lyle, MD, Chief Medical Officer
- Vladislav Chizhevsky, MD SSBBP, Medical Director, Aliso Viejo, California
- J. Christopher Mixon, MD, Medical Director, Nashville, Tennessee
- Anahit Nowrouzi, MD, Medical Director, Fort Myers, Florida
- Tricia Peters, MD, Medical Director, Houston, Texas Molecular Pathologist, Pharma Services
- Yin Xu, MD PhD FCAP, Medical Director, Carlsbad and Atlanta; Global Medical Director, Pharma Services
- Renuka Agrawal, MD, Senior Hematopathologist
- Todd S. Barry, MD PhD, Senior Hematopathologist
- Bora Baysal, MD, PhD, Senior Hematopathologist
- Saskia Boisot, MD, Senior Hematopathologist
- Wayne W. Chen, MD PhD, Director of Hematopathology Services
- Rachel Flamholz, MD, Senior Hematopathologist
- Michael Hayes, MD, Senior Hematopathologist / Surgical Pathologist
- Anselm Hii, MD, Director of Hematopathology Services
- Thanh Ho, MD, Senior Hematopathologist
- Kim Janatpour, MD MA, Senior Hematopathologist
- Shiping Jiang, MD PhD, Senior Hematopathologist and Surgical Pathologist
- Sameer S. Khatri, MD, Hematopathologist
- Madeleine Kraus, MD, Senior Hematopathologist
- Brian Kwok, MD FCAP, Corporate Director of Hematopathology
- Keming Lin, MD MS FCAP, Senior Hematopathologist
- Robert Lin, MD, Senior Hematopathologist
- Russell L. Maiese, M.D., Senior Hematopathologist
- Mojdeh Naghashpour, MD PhD, Senior Hematopathologist
- Viera Nelson, MD, Senior Hematopathologist
- Dennis P. O’Malley, MD, Senior Hematopathologist
- Anthony Padula, MD, Senior Hematopathologist
- Munir Shahjahan, MD MPH, Senior Hematopathologist
- Jesalyn J. Taylor, MD, Senior Hematopathologist
- Jian-Feng Wang, MD PhD, Senior Hematopathologist
- Zhao Wu, MD PhD FCAP, Senior Hematopathologist
- Aine Yung, MD FCAP, Senior Hematopathologist
- Sadiq Zaman, MD, Senior Hematopathologist
- Guohua Zhao, MD PhD, Senior Hematopathologist
- Mitual Amin, MD, Senior Surgical Pathologist
- Jerry Chu, MD PhD, Senior Surgical Pathologist
- Ted Farzaneh, MD, Senior Surgical Pathologist
- Thomas K. Lee, MD PhD, Director of Surgical Pathology Services
- Takako Mitsuhashi, MD PhD, Senior Dermatopathologist and Surgical Pathologist
- Robert Schwartz, MD, Senior Surgical Pathologist
- Yae K (Kay) Suh, MD, Senior Surgical Pathologist
- Matthew Geller, DO, Molecular Pathologist
- Hao Ho, MD, Molecular Pathologist
- Jennifer Hummel, MD, Senior Molecular Pathologist
- Armen Kaysan, MD, Molecular Pathologist
- Kalpana S. Reddy, MD, Hematopathologist and Molecular Pathologist
- Saed Sadeghi, MD, Molecular Pathologist
- Ying Wang, MD PhD, Molecular Pathologist
- Shehla Arain, MD, Senior Surgical Pathologist, Pharma Services
- Chunghun George Chang, md, Surgical and Hemepath Pathologist, Pharma Services
- Indu Gupta, MD, Surgical Pathologist, Pharma Services
- Valerie Harris-Morris, MD, Hemepath Pathologist, Pharma Services
- Albert Ho, Director of Pharma Pathology Services
- Henry Tsai, MD PhD, Surgical Pathologist, Pharma Services
- Sujata Chakraborty, PhD FACMGG, Director, Cytogenetics and Molecular Genetics
- Li Cheng, PhD FACMG, Associate Director of Cytogenetics
- Liang Dong, MD PhD, Director of Cytogenetic Services
- Mohamed M. Elnaggar, MD MS FACMG, Director of Cytogenetic Services
- Michele Hibbard/Kempik, PhD FACMG, Director of Genetics
- Fernando J. López-Díaz, PhD, Director of Clinical Science, Research and Development
- John R. McGill, PhD FACMGG, Medical Director of Cytogenetics and Technical Director of FISH
- Mike Nahorski, PhD, Director, Clinical and Scientific Alliances
- Farzad Nooraie, MD, Director of Cytogenetic Services
- Róisín Puentes, PharmD, PhD, Medical Science Liaison, Medical Affairs
- Siby Sebastian, Ph.D, FACMGG, DABCC, Lab Director, Research Triangle Park (RTP), North Carolina
- Guoxian Sun, MD DABMG FACMG, Director of Cytogenetic Services
- Jadwiga Szymanska, PhD FACMG, Director of Cytogenetics
- Maya Thangavelu, PhD, Medical Director of Cytogenetics and Technical Director of FISH
- Qinqin Zha, PhD, Principal Scientist, Associate Director, Scientific Affairs
- John N. Allan, MD, Scientific Advisory Board Member
- Rafael Bejar, MD, PhD, Scientific Advisory Board Member
- James R. Berenson, MD, Scientific Advisory Board Member
- Riccardo Dalla-Favera, PhD, Scientific Advisory Board Member
- James Downing, MD, Scientific Advisory Board Member
- Bernard A Fox, PhD, Scientific Advisory Board Member
- Gregory Hess, MD, Scientific Advisory Board Member
- Hatim Husain, MD, Scientific Advisory Board Member
- Tibor Kovacsovics, MD, Scientific Advisory Board Member
- Razelle Kurzrock, MD, Scientific Advisory Board Member
- Gail J. Roboz, MD, Scientific Advisory Board Member
- Steven T. Rosen, MD, FACP, FASCO, FAIMBE, Scientific Advisory Board Member
- Mark A. Rubin, MD, Scientific Advisory Board Member
Last updated: 2024-12-31
OncoCyte Corporation
Determa Rx
Onco Cyte Corporation, based in Irvine, California, develops and commercializes molecular diagnostics tests for cancer detection, including Determa Rx and Determa IO.
Symbol: OCX
Recent Price: $2.45
Industry: Biotechnology
CEO: Mr. Joshua Riggs
Sector: Healthcare
Employees: 43
Address: 15 Cushing, Irvine, CA 92618
Phone: 949 409 7600
Leadership
- Josh Riggs, President & Chief Executive Officer
- Prof. Dr. Ekkehard Schütz, MD, PhD, FAACC, Chief Science Officer
- Yuh-Min (Johnson) Chiang, PhD, Chief Technology Officer
- Andrea James, Chief Financial Officer
- Sandra O’Donald, Senior Vice President, Business Operations
- Ryan Andrews, Vice President, Commercial
- Peter Hong, Vice President, General Counsel
- James Liu, Senior Director, Controller & Principal Accounting Officer
Last updated: 2024-12-31
PDS Biotechnology Corporation
PDS0101
PDS Biotechnology Corporation is a clinical-stage biopharmaceutical company focused on developing multifunctional cancer immunotherapies. Its lead product candidate, PDS0101, is in Phase II clinical trial for treating various human papillomavirus-associated malignancies.
Symbol: PDSB
Recent Price: $1.69
Industry: Biotechnology
CEO: Dr. Frank K. Bedu-Addo Ph.D.
Sector: Healthcare
Employees: 25
Address: 25B Vreeland Road, Florham Park, NJ 07932
Phone: 800 208 3343
Leadership
- Frank Bedu-Addo, Ph.D., Chief Executive Officer, Director
- Stephan Toutain, Chief Operating Officer
- Lars Boesgaard, Chief Financial Officer
- Gregory Conn, Ph.D., Chief Scientific Officer
- Kirk Shepard, M.D., Chief Medical Officer
- Spencer Brown, Senior Vice-President, General Counsel, Corporate Secretary and Compliance Officer
- Rory Cullinane, Vice President of Quality
- Joe Dervan, Ph.D., Vice President of Research and Development
- David Schaaf, M.D., Vice President of Medical Affairs
- Sir Richard Sykes, Director
- Ilian Iliev, Ph.D., Director
- Gregory Freitag, J.D., CPA, Director
- Otis W. Brawley, M.D., Director
- Kamil Ali-Jackson, J.D., Director
- Stephen Glover, Chairman
Last updated: 2024-12-31
Veracyte, Inc.
Afirma Genomic Sequencing Classifier, Xpression Atlas, Decipher Prostate, Prosigna Breast Cancer Assay, Percepta Genomic Sequencing Classifier, Envisia Genomic Classifier, Immunoscore Colon Cancer test
Veracyte, Inc. operates as a diagnostics company worldwide, providing genomic testing solutions for various cancers and diseases, aiming to improve outcomes by avoiding unnecessary surgeries and enhancing treatment decisions.
Symbol: VCYT
Recent Price: $40.00
Industry: Biotechnology
CEO: Mr. Marc A. Stapley
Sector: Healthcare
Employees: 815
Address: 6000 Shoreline Court, South San Francisco, CA 94080
Phone: 650 243 6300
Last updated: 2024-12-31
Arcus Biosciences, Inc.
Cancer Therapies
Arcus Biosciences, Inc. is a clinical-stage biopharmaceutical company developing and commercializing cancer therapies, with a pipeline including products like Etrumadenant, Zimberelimab, and Domvanalimab among others.
About | About | Leadership | Directors | About | Contact | Contact | Contact | Contact | Contact | Careers | About | About | About | About | Careers | About | Jobs | About | About
Symbol: RCUS
Recent Price: $14.91
Industry: Biotechnology
CEO: Dr. Terry J. Rosen Ph.D.
Sector: Healthcare
Employees: 577
Address: 3928 Point Eden Way, Hayward, CA 94545
Phone: 510 694 6200
Last updated: 2024-12-31
Galecto, Inc.
GB2064
Galecto, Inc. is a clinical-stage biotechnology company focused on developing molecules for the treatment of fibrosis, cancer, inflammation, and related diseases. Their lead product candidate, GB2064, is in Phase IIa for myelofibrosis. The company also advances other candidates targeting severe fibrotic lung diseases and cancer.
Symbol: GLTO
Recent Price: $4.60
Industry: Biotechnology
CEO: Dr. Hans T. Schambye M.D., Ph.D.
Sector: Healthcare
Employees: 13
Address: 75 State Street, Boston, MA 02109
Phone: 457 070 5210
Last updated: 2024-12-31
Lantheus Holdings, Inc.
DEFINITY, Techne Lite, Xenon-133, Neurolite, Cardiolite, Thallium-201, Gallium-67, AZEDRA, Automated Bone Scan Index, Cobalt (Co 57), RELISTOR
Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide.
Symbol: LNTH
Recent Price: $89.13
Industry: Drug Manufacturers - Specialty & Generic
CEO: Mr. Brian A. Markison
Sector: Healthcare
Employees: 834
Address: 331 Treble Cove Road, North Billerica, MA 01862
Phone: 978 671 8001
Leadership
- Brian Markison, Chief Executive Officer
- Paul Blanchfield, President
- Jeff Humphrey, MD, Chief Medical Officer
- Robert J. Marshall Jr., Chief Financial Officer
- Amanda Morgan, Chief Commercial Officer
- Daniel Niedzwiecki, Chief Administrative Officer, General Counsel and Corporate Secretary
- Jean-Claude Provost, MD, Chief Science Officer
- Jamie Spaeth, Chief People Officer
- Cheryl Ball, Senior Vice President, Strategy and Enterprise Planning
- Dorothy Barr, Senior Vice President, Manufacturing and Technical Operations
- Kim Brown, Chief Accounting Officer
- Lee Anne Howe, Chief Information Officer
- Linda Lennox, Chief of Staff & Vice President, Corporate Communications
- Joann Nestor, Senior Vice President, Legal Affairs
- Andrea Sabens, Vice President, Business Optimization
- Carol Walker, Senior Vice President, Quality
- Mary Anne Heino, Chairperson of the Board
- Minnie Baylor-Henry, Director
- Gérard Ber, PhD, Director
- Julie Eastland, Director
- Samuel Leno, Director
- Heinz Mäusli, Director
- Julie McHugh, Director
- Gary J. Pruden, Director
- James H. Thrall, MD, Director
Last updated: 2024-12-31